Tarsus Pharmaceuticals Inc (TARS)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$3.49B
EV to revenue ratio (TTM)
4.61
EV to ebitda
-3.23
Financial Performance
Revenue (TTM)
$0.68B
Gross profit (TTM)
$0.57B
EBITDA
-$0.06B
Profitability
Operating margin (TTM)
-16.20%
Profit margin
-102.90%
Return on assets (TTM)
-7.88%
Return on equity (TTM)
-319.80%
Per Share Metrics
Revenue per share (TTM)
$15.54
EPS
-$15.86
Diluted EPS (TTM)
-$15.86
Book value
$2.11
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
56.82
PEG ratio
n/a
Price to sales ratio (TTM)
5.12
Price to book ratio (TTM)
32.51
Growth
Quarterly earnings growth (YoY)
63.90%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
1
Buy
9
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.33